Published in Circulation on May 22, 2012
Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction. J Thorac Cardiovasc Surg (2015) 2.02
Left ventricular assist devices: a kidney's perspective. Heart Fail Rev (2015) 1.99
HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis. Ann Thorac Surg (2013) 1.41
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? J Card Fail (2015) 1.40
Clinical outcomes after continuous-flow left ventricular assist device: a systematic review. Circ Heart Fail (2014) 1.24
Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate? Curr Heart Fail Rep (2013) 1.15
An insight into short- and long-term mechanical circulatory support systems. Clin Res Cardiol (2014) 1.07
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with a left ventricular assist device already in place. Tex Heart Inst J (2015) 1.00
HeartMate 3-a "Step" in the right direction. J Thorac Dis (2017) 0.96
Dealing with surgical left ventricular assist device complications. J Thorac Dis (2015) 0.90
Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device. Eur J Heart Fail (2014) 0.90
State of the art of mechanical circulatory support. Tex Heart Inst J (2014) 0.89
Acquired von Willebrand syndrome associated with left ventricular assist device. Blood (2016) 0.88
Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation. Eur J Cardiothorac Surg (2014) 0.87
Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support. Heart Fail Rev (2015) 0.86
Pump thrombosis-A riddle wrapped in a mystery inside an enigma. Ann Cardiothorac Surg (2014) 0.85
Recurrent Early Thrombus Formation in HeartMate II Left Ventricular Assist Device. J Investig Med High Impact Case Rep (2013) 0.84
Devices in the management of advanced, chronic heart failure. Nat Rev Cardiol (2012) 0.83
Patient-centered care for left ventricular assist device therapy: current challenges and future directions. Curr Opin Cardiol (2016) 0.83
Sex-specific outcomes in patients receiving continuous-flow left ventricular devices as a bridge to transplantation or destination therapy. ASAIO J (2014) 0.82
Current state-of-the-art of device therapy for advanced heart failure. Croat Med J (2014) 0.81
Left ventricular assist devices as a bridge to cardiac transplantation. J Thorac Dis (2014) 0.80
Neurological complications and outcomes in the Berlin Heart EXCOR® pediatric investigational device exemption trial. J Am Heart Assoc (2015) 0.80
Identification of differentially expressed transcripts and pathways in blood one week and six months following implant of left ventricular assist devices. PLoS One (2013) 0.79
Long-term continuous-flow left ventricular assist devices (LVAD) as bridge to heart transplantation. J Thorac Dis (2015) 0.79
Laparoscopic nephroureterectomy in a patient with a left ventricular assist device. Can Urol Assoc J (2014) 0.78
Rethinking Phase II Clinical Trial Design in Heart Failure. Clin Investig (Lond) (2013) 0.78
Initial experience in Japan with HeartWare ventricular assist system. J Artif Organs (2014) 0.78
Pulsatile-flow mechanical circulatory support (MCS) as a bridge to transplantation or recovery. Single-centre experience with the POLCAS system in 2014. Kardiochir Torakochirurgia Pol (2015) 0.77
Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study. Tex Heart Inst J (2015) 0.76
Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets. Curr Opin Cardiol (2016) 0.76
Medical management of patients with continuous-flow left ventricular assist devices. Curr Treat Options Cardiovasc Med (2014) 0.76
Current approaches to device implantation in pediatric and congenital heart disease patients. Expert Rev Cardiovasc Ther (2015) 0.76
Mechanical circulatory support devices as destination therapy-current evidence. Ann Cardiothorac Surg (2014) 0.76
Left ventricular assist device patient selection: do risk scores help? J Thorac Dis (2015) 0.75
Role of gastroesophageal reflux disease in lung transplantation. World J Transplant (2017) 0.75
A bridge far enough? Circulation (2012) 0.75
Ventricular assist device use in congenital heart disease with a comparison to heart transplant. J Comp Eff Res (2014) 0.75
Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery. PLoS One (2017) 0.75
Preoperative liver dysfunction influences blood product administration and alterations in circulating haemostatic markers following ventricular assist device implantation. Eur J Cardiothorac Surg (2014) 0.75
Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry. J Heart Lung Transplant (2015) 0.75
Device therapy: New centrifugal pump noninferior. Nat Rev Cardiol (2012) 0.75
Chronic outpatient management of patients with a left ventricular assist device. J Thorac Dis (2015) 0.75
Left ventricular assist device implantation strategies and outcomes. J Thorac Dis (2015) 0.75
Medical Management of Pump Related Thrombosis in Patients with Continuous Flow Left Ventricular Assist Devices: A Systematic Review and Meta-analysis. ASAIO J (2016) 0.75
Advanced therapies for end-stage heart failure. Curr Cardiol Rev (2015) 0.75
Early feasibility testing and engineering development of a sutureless beating heart connector for left ventricular assist devices. ASAIO J (2014) 0.75
How to cope with a temporarily aborted transplant program: solutions for a prolonged waiting period. Ann Transl Med (2015) 0.75
New pharmacological and technological management strategies in heart failure. Vasc Health Risk Manag (2017) 0.75
Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review. Neurocrit Care (2017) 0.75
Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation. Heart Vessels (2015) 0.75
Long-term use of left ventricular assist devices: a report on clinical outcomes. Can J Surg (2017) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med (2005) 6.32
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol (2007) 6.12
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. A rebuttal. J Thorac Cardiovasc Surg (2003) 5.03
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation (2007) 4.67
Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant (2013) 4.60
Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med (2010) 4.31
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol (2009) 4.03
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant (2010) 4.00
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol (2010) 3.63
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg (2014) 3.28
Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation (2006) 3.27
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int (2008) 3.12
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol (2011) 3.06
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol (2010) 3.03
Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA (2008) 3.01
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol (2006) 2.95
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail (2009) 2.89
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant (2013) 2.71
The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant (2012) 2.69
Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol (2008) 2.66
Metabolic gene expression in fetal and failing human heart. Circulation (2001) 2.59
INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant (2009) 2.49
Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation (2007) 2.49
Saddle-shape annuloplasty increases mitral leaflet coaptation after repair for flail posterior leaflet. Ann Thorac Surg (2011) 2.42
Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol (2005) 2.38
Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol (2012) 2.37
The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol (2008) 2.37
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant (2008) 2.32
Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg (2010) 2.29
Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol (2011) 2.22
Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22
INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant (2008) 2.17
Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networks. Physiol Genomics (2004) 2.17
Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg (1989) 2.17
Preoperative hematocrit is a powerful predictor of adverse outcomes in coronary artery bypass graft surgery: a report from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2013) 2.15
Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation (2002) 2.15
Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation (2005) 2.14
Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol (2003) 2.10
Association of body mass index with new-onset atrial fibrillation after coronary artery bypass grafting operations. Ann Thorac Surg (2011) 2.06
Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg (1992) 2.06
Left ventricular assist device management in the ICU. Crit Care Med (2014) 2.04
Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care (2007) 2.04
Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant (2011) 2.03
Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation (2009) 2.02
Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation (2006) 2.01
Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant (2011) 2.01
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Ventricular restraint prevents infarct expansion and improves borderzone function after myocardial infarction: a study using magnetic resonance imaging, three-dimensional surface modeling, and myocardial tagging. Ann Thorac Surg (2007) 2.00
Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy. Circ Heart Fail (2011) 1.99
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation (2003) 1.99
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol (2009) 1.98
High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail (2010) 1.96